Recherche
Voies oncogéniques dans le cancer du poumon : A. Maraver

Liste des Publications

Xiong H, Mancini M, Gobert M, Shen S, Furtado G, Lira S, Parkhurst C, Brengues M, Tadokoro C, Trimarchi T, Singh A, Khiabanian H, Minuzzo S, Indraccolo S, Lobry C, Aifantis I, Herranz D, Lafaille J, Maraver A Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia. Theranostics. 2021;11(4):1594-1608. doi:10.7150/thno.48067

Kantar D, Mur E, Mancini M, Slaninova V, Salah Y, Costa L, Forest E, Lassus P, Géminard C, Boissière-Michot F, Orsetti B, Theillet C, Colinge J, Benistant C, Maraver A, Heron-Milhavet L, Djiane A MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis. Sci Rep. 2021;11(1):5752. doi:10.1038/s41598-021-85056-1

Mancini M, Thomas Q-D, Bourdel S, Papon L, Bousquet E, Jalta P, La Monica S, Travert C, Alfieri R, Quantin X, Cañamero M, Maraver A Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers. 2021;13(14):3441. doi:10.3390/cancers13143441

Thomas Q, Sinoquet L, Maraver A, Quantin X Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report. Clin Case Rep. 2021;9(5). doi:10.1002/ccr3.3973

Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol J-L, Calvayrac O, Moll H, Glasson Y, Pirot N, Turtoi A, Cañamero M, Wong K-K, Yarden Y, Casanova E, Soria J-C, Colinge J, Siebel C, Favre G, Paz-Ares L, Maraver A Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma. J Clin Invest. 2020;130(2):612-624. doi:10.1172/JCI126896

Nokin M-J, Darbo E, Travert C, Drogat B, Lacouture A, San José S, Cabrera N, Turcq B, Prouzet-Mauleon V, Falcone M, Villanueva A, Wang H, Herfs M, Mosteiro M, Jänne P, Pujol J-L, Maraver A, Barbacid M, Nadal E, Santamaría D, Ambrogio C Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma. JCI Insight. 2020;5(15). doi:10.1172/jci.insight.137869

Bianco J, Bergoglio V, Lin Y-L, Pillaire M-J, Schmitz A-L, Gilhodes J, Lusque A, Mazières J, Lacroix-Triki M, Roumeliotis T, Choudhary J, Moreaux J, Hoffmann J-S, Tourrière H, Pasero P Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner. Nat Commun. 2019;10(1):910. doi:10.1038/s41467-019-08886-8

Paul C, Delpech H, Haouzi D, Hamamah S, Sardet C, Fabbrizio E Coprs inactivation leads to a derepression of LINE1 transposons in spermatocytes. FEBS Open Bio. 2019;9(1):159-168. doi:10.1002/2211-5463.12562

Pujol J-L, Greillier L, Audigier-Valette C, Moro-Sibilot D, Uwer L, Hureaux J, Guisier F, Carmier D, Madelaine J, Otto J, Gounant V, Merle P, Mourlanette P, Molinier O, Renault A, Rabeau A, Antoine M, Denis M, Langlais A, Morin F, Souquet P-J A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial. J Thorac Oncol. 2019;14(5):903-913. doi:10.1016/j.jtho.2019.01.008

Merveilleux du Vignaux C, Dansin E, Mhanna L, Greillier L, Pichon E, Kerjouan M, Mennecier B, Westeel V, Robert M, Quantin X, Thiberville L, Lena H, Molina T, Calcagno F, Fournel P, Mazières J, Besse B, Girard N Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort. J Thorac Oncol. 2018;13(11):1762-1770. doi:10.1016/j.jtho.2018.08.005

Pujol J-L, Jean-Baptiste S, Bommart S, Roch B Synchronous multiple non-small cell lung cancers in an allograft lung recipient. Lung Cancer. 2018;124. doi:10.1016/j.lungcan.2018.07.024

Roth L, Srivastava S, Lindzen M, Sas-Chen A, Sheffer M, Lauriola M, Enuka Y, Noronha A, Mancini M, Lavi S, Tarcic G, Pines G, Nevo N, Heyman O, Ziv T, Rueda O, Gnocchi D, Pikarsky E, Admon A, Caldas C, Yarden Y SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors. Sci Signal. 2018;11(515). doi:10.1126/scisignal.aan0949

Hamann H, Pujol J-L Introduction to the Special Section: The Experience and Impact of Lung Cancer Stigma. J Thorac Oncol. 2018;13(8):1053-1054. doi:10.1016/j.jtho.2018.06.006

Middleton G, Gridelli C, Pujol J-L, Reck M, Ramlau R, Parente B, Pieters T, Visseren-Grul C, John W, Zimmermann A, Chouaki N, Paz-Ares L Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Curr Med Res Opin. 2018;34(5):865-871. doi:10.1080/03007995.2018.1439462

Solassol J, Quantin X, Larrieux M, Senal R, Audran P, Grand D, Mangé A, Diamandis E, Vendrell J Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer. Clin. Chem. Lab. Med.. 2018;56(9):e243-e246. doi:10.1515/cclm-2017-0967

Sanclemente M, Francoz S, Esteban-Burgos L, Bousquet-Mur E, Djurec M, Lopez-Casas P, Hidalgo M, Guerra C, Drosten M, Musteanu M, Barbacid M c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling. Cancer Cell. 2018;33(2):217-228.e4. doi:10.1016/j.ccell.2017.12.014

Mancini M, Gaborit N, Mazzeo L, Romaniello D, Salame T, Lindzen M, Mahlknecht G, Enuka Y, Burton D, Roth L, Noronha A, Marrocco I, Adreka D, Altstadter R, Bousquet E, Downward J, Maraver A, Krizhanovsky V, Yarden Y An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors. EMBO Mol Med. 2018;10(2):294-308. doi:10.15252/emmm.201708076

Romaniello D, Mazzeo L, Mancini M, Marrocco I, Noronha A, Kreitman M, Srivastava S, Ghosh S, Lindzen M, Salame T, Onn A, Bar J, Yarden Y A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clin. Cancer Res.. Jul 02, 2018. doi:10.1158/1078-0432.CCR-18-0450

Calvayrac O, Mazières J, Figarol S, Marty-Detraves C, Raymond-Letron I, Bousquet E, Farella M, Clermont-Taranchon E, Milia J, Rouquette I, Guibert N, Cadranel J, Mathiot N, Savina A, Pradines A, Favre G The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism. EMBO Mol Med. 2017;9(2):238-250. doi:10.15252/emmm.201606646

Chebli K, Papon L, Paul C, Garcel A, Campos N, Scherrer D, J Ehrlich H, Hahne M, Tazi J The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages. Sci Rep. 2017;7(1):4860. doi:10.1038/s41598-017-04071-3

Langer C, Paz-Ares L, Wozniak A, Gridelli C, de Marinis F, Pujol J-L, San Antonio B, Chen J, Liu J, Oton A, Visseren-Grul C, Scagliotti G Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies. Clin Lung Cancer. 2017;18(5):489-496. doi:10.1016/j.cllc.2017.04.003

Basse C, Thureau S, Bota S, Dansin E, Thomas P-A, Pichon E, Lena H, Massabeau C, Clément-Duchene C, Massard G, Westeel V, Quantin X, Oulkhouir Y, Danhier S, Lerouge D, Tanguy R, Thillays F, Le Pechoux C, Dubray B, Thiberville L, Besse B, Girard N Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort. J Thorac Oncol. 2017;12(11):1715-1722. doi:10.1016/j.jtho.2017.07.023

Bommart S, Berthet J, Durand G, Pujol J, Mathieu C, Marty-Ané C, Kovacsik H Imaging of postoperative complications following surgery for lung cancer. Diagn Interv Imaging. 2017;98(1):11-20. doi:10.1016/j.diii.2015.06.022

Antonia S, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee K, de Wit M, Cho B, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim Y-C, Karapetis C, Hiret S, Ostoros G, Kubota K, Gray J, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis P, Özgüro?lu M Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. N. Engl. J. Med.. 2017;377(20):1919-1929. doi:10.1056/NEJMoa1709937

Vendrell J, Taviaux S, Béganton B, Godreuil S, Audran P, Grand D, Clermont E, Serre I, Szablewski V, Coopman P, Mazières J, Costes V, Pujol J-L, Brousset P, Rouquette I, Solassol J Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches. Sci Rep. 2017;7(1):12510. doi:10.1038/s41598-017-12679-8



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés